Fundies. English
Eucrates Biomedical Acquisition Corp.
EDGAR13 filing records in this dataset, filed from 2020-10-06 to 2023-04-13. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- Not available
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 2.98 million Unit_Standard_shares_3639gPbDzkWZ2DOHu54DWA Source
Exact value
2979499 Unit_Standard_shares_3639gPbDzkWZ2DOHu54DWA
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2023-04-13.
Financial data available through: 2022-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 2 of 11 periods available· newest 2022-12-31
- Net income: 2 of 11 periods available· newest 2022-12-31
- Operating cash flow: 2 of 11 periods available· newest 2022-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 2 of 11 periods available· newest 2022-12-31
- Total liabilities: 2 of 11 periods available· newest 2022-12-31
- Current assets: 2 of 11 periods available· newest 2022-12-31
- Current liabilities: 2 of 11 periods available· newest 2022-12-31
- cash and cash equivalents: No compatible figures in this window
- long term debt: No compatible figures in this window
- Shares outstanding: Multiple units; comparison withheld· newest 2021-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
-36.7%Prior period
Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 3.82 million
–
Current period
Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 2.42 million
–
Exact inputs and evidence
2419605 − 3824229 = -1404624 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg
3824229 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg · 2021-01-01 – 2021-12-31
Inspect prior input Prior source2419605 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg · 2022-01-01 – 2022-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 128,183Prior period
−Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 502,108
–
Current period
−Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 630,291
–
Exact inputs and evidence
-630291 − -502108 = -128183 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg
-502108 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-630291 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg · 2022-01-01 – 2022-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 3.82 million Exact valueExact value: 3824229 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 2021-01-01 – 2021-12-31: 3824229 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 502,108 Exact valueExact value: -502108 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 2021-01-01 – 2021-12-31: -502108 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 2.42 million Exact valueExact value: 2419605 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 2022-01-01 – 2022-12-31: 2419605 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 630,291 Exact valueExact value: -630291 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg 2022-01-01 – 2022-12-31: -630291 Unit_Standard_USD_ux0rIJ6FQ0iHFl3l-HMGdg Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
13 filings · 436 latest values · 436 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001822929, 1822929, EUCRU, edgar:1822929
Also known as EUCRATES BIOMEDICAL ACQUISITION CORP., Eucrates Biomedical Acquisition Corp.